Put four GLP-1 sellers side by side and the assumption is that four businesses looked at the same market and priced it differently. Sometimes that is exactly what happened. Sometimes it is one business, and the four prices are four settings in one configuration file. On this market, 8 storefronts are known to be the second case — and what they charge each other’s customers is the part worth seeing. It changes how much weight a side-by-side comparison of them deserves.
Same build, 1.9 times the price
Of the 8 brands in the group, 5 publish a billed figure for compounded semaglutide by injection. They are $129, $149, $199, $249, $249. The cheapest and the dearest are 1.9 times apart, and the product, the software and — as far as anything visible from outside can establish — the operation behind them are the same.
On tirzepatide the same group publishes $129, $299, $299, $299, $349, a spread of 2.7 times from $129 to $349. The brand charging least on one molecule is not automatically the one charging least on the other, which is what you would expect from separate pricing decisions inside one system rather than from separate businesses.
And 3 of them publish nothing
Three brands in the group carry no figure this site can rank. That is not a low price and it is not an oversight to be averaged away — it is a different fact. Where their treatment pages should carry a rate, they carry a consultation prompt, and the figures sitting in their page data turn out to be the shared template’s defaults rather than anything a buyer is charged.
Three silent brands in one group is also a reminder that a published figure is itself a disclosure. The ranked board carries only sellers that publish one.
What a shopper should take from it
Not that these brands are dishonest — nothing here establishes that, and running several storefronts from one platform is an ordinary commercial arrangement. What it establishes is narrower and more useful: comparing several of them is not comparing several companies, so the reassurance a shortlist normally provides is absent, and the cheapest of them is the one to take.
More generally, it is a reason to weigh what a seller discloses over how many sellers agree with each other. A named compounding pharmacy, a stated billing interval and a published dose ladder are all checkable from outside. Brand count is not. Our full price distribution shows where any of these figures sits in the wider market, and the gap between advertised and billed figures is the other thing a comparison page cannot show you.
Every figure above is computed from this site’s own records at build time, across 456 priced sellers, most recently read September 2026.